REFERENCES
- WHO. Control of Chagas disease: Second Report of the Expert Committee (Geneve), Technical Report Series 905. 2002.
- Hepburn NC. Cutaneous leishmaniasis: current and future management. Expert Rev Anti Infect Ther 2003; 1: 563–70.
- Gamier T, Croft SL. Topical treatment for cutaneous leishmaniasis. Curr. Opin. Investig. Drugs 2002; 3: 538–544.
- Coura JR, De Castro SL. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz 2002; 97: 3–24.
- Croft SL, Yardley V. Chemotherapy of leishmaniasis. Curr Pharm Des 2002; 8: 319–342.
- De Conti R, Gimenez SMN, Haun M et al. Synthesis and biological activities of N,N-dimethyl-2-propen-1-amine derivatives. Eur J Med Chem 1996a; 31: 915-918.
- De Conti R, Santa-Rita RM, De Souza EM et al. In vitro trypanocidal activities of a novel series of N,N-dimethyl-2-propen-1-amine derivatives. Microbios 1996b; 85: 83-87.
- De Conti R, Oliveira DA, Fernandes AMP et al. Application of a multi-endpoint cytotoxicity assay to the try-panocidal compounds 2-propen-1-amine derivatives and deter-mination of their acute toxicity. In Vitro Toxicol 1998; 11: 153–160.
- De Souza AO, Hemerly FP, Busollo AC et al. 3-[4'-Bromo-(1, 1 '-biphenyl)-4-yl]-N,N-dimethyl-3-(2-thienyl)-2-propen-1-amine: synthesis, cytotoxicity, and leishmanicidal, trypanocidal and antimycobacterial activities. J Antimicrob Chemother 2002; 50: 629–637.
- Pereira DG, De Castro SL, Durán N. Activity of N,N-dimethyl-2-propen-1-amine derivatives in mice experimentally infected with Trypanosoma cruzi. Acta Trop 1998; 69: 205–211.
- De Souza AO, Sato DN, Aily DCG et al. In vitro activ-ity of N,N-dimethyl-2-propen-1-amines against Mycobacterium tuberculosis. J Antimicrob Chemother 1998; 42: 407–408.
- De Souza AO, Alderete JB, Sato DN et al. Structure activity relationship analysis of 4'-bromo-[1,1'-biphenyl] 4 yl 4 X-phenylmetanone derivatives and activities against Mycobacterium tuberculosis. Arzneim-Forsch 1999; 49: 1025–1029.
- De Souza AO, Santos Jr RR, Ferreira-Jitlio JF et al. Synthesis, antimycobacterial activities and cytotoxicity on V79 of 314'-Y-(1,1'-biphenyl)-4-yli-N,N-dimethyl 3 (4 X phenyl)-2-propen-1-amine derivatives. Eur J Med Chem 2001; 36: 843–850.
- De Souza AO, Santos Jr RR, Melo PS et al. Antimycobacterial activity of 4"-bromo-[1,1"-biphenyl] 4 yl 4 X phenylmethanone derivatives and their acute toxicity and cyto-toxicity. Pharmazie 2001; 56: 871–874.
- Pinto AV, Neves-Pinto C, Pinto MCFR et al. Trypanocidal activity of synthetic heterocyclic derivatives of active quinones from Tabebuia sp. Arzneim-Forsch 1997; 47: 74–79.
- De Castro SL, Soeiro MNC, Higashi KO et al. Differential effect of Amphotericin B on the three evolutive stages of Trypanosoma cruzi and on the host cell-parasite interaction. Braz J Med Biol Res 1993; 26: 1219–1229.
- Canto-Cavalheiro MM, Echevarria A, Araftjo CAC et al. The potential effects of new synthetic drugs against Leishmania amazonensis and Trypanosoma cruzi. Microbios 1997; 90: 51–60.